Answers are grounded in this paper and cite their sources.
Background/Objectives: Bloodstream infections (BSIs) are a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), and reported incidence depends on how skin commensals are adjudicated. We describe the epidemiology, microbiology, risk factors, and survival impact of early (day 0–30) bacterial BSI at a Turkish transplant center. Methods: We retrospectively studied 155 consecutive allo-HSCT episodes in 153 adults (April 2017–January 2026). Single-isolate coagulase-negative staphylococci (CoNS) were classified as contaminants. Cumulative incidence was estimated with the Aalen–Johansen estimator and survival with day-30 landmark and time-dependent Cox models. Results: Bacterial BSI occurred in 20 episodes (30-day cumulative incidence 12.9%, 95% CI 8.2–18.7) at a median of 14 days; counting single-isolate CoNS would have raised incidence to 40.0%. Of 22 isolates, 15 (68.2%) were Gram-negative and 12 (54.5%) were Escherichia coli. An extended-spectrum β-lactamase phenotype was present in nine episodes. Among 14 Gram-negative episodes with susceptibility data, 71.4% were fluoroquinolone-resistant and 92.9% meropenem-susceptible; empirical therapy was active in 16 of 20 episodes (80.0%). No baseline covariate predicted BSI, and early BSI was not associated with overall survival (adjusted HR 0.75, 95% CI 0.34–1.64). Conclusions: Early bacterial BSI was predominantly Gram-negative and E. coli-driven, with frequent fluoroquinolone resistance but preserved carbapenem susceptibility. Contaminant adjudication substantially altered incidence and should be stated explicitly.
No takes yet. Share an insight, caveat, or question.
Sarıcı et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: